| Infection |
NCT01079039: Survey for Usage Rates of Pertussis Vaccines in the State of Wisconsin |
|
|
| Active, not recruiting | 4 | 12000 | US | | Sanofi Pasteur, a Sanofi Company | Pertussis | 02/15 | 06/16 | | |
NCT00004317: Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis |
|
|
| Recruiting | 4 | 600 | US | Leucovorin calcium, Pyrimethamine, Spiramycin, Sulfadiazine | National Institute of Allergy and Infectious Diseases (NIAID), University of Chicago | Toxoplasmosis | 12/30 | 12/30 | | |
NCT01821794: Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B |
|
|
| Active, not recruiting | 3 | 26 | US | Peginterferon and Tenofovir | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Chronic Hepatitis B e Antigen Negative, Chronic Hepatitis B e Antigen Positive | 03/13 | 12/17 | | |
NCT02131025: A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen |
|
|
| Active, not recruiting | 3 | 428 | US, Canada | ABC/DTG/3TC FDC, Ongoing cART regimen | ViiV Healthcare, PPD, GlaxoSmithKline | Infection, Human Immunodeficiency Virus | 04/15 | 10/15 | | |
NCT00852345: Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy |
|
|
| No Longer Available | 3 | | US | clofazamine | Kaiser Permanente, Health Resources and Services Administration (HRSA) | Leprosy | | | | |
NCT02120196: Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis |
|
|
| Recruiting | 3 | 100 | RoW | Rifaximin, Gastrobiotic, Trencedia, Norfloxacin, Epinor | Sherief Abd-Elsalam, Tanta University | Spontaneous Bacterial Peritonitis, Ascites, Liver Cirrhosis | 12/23 | 12/23 | | |
| Active, not recruiting | 2 | 40 | US | VRX496-transduced autologous CD4 T cells | VIRxSYS Corporation | HIV Infections | 01/09 | 06/23 | | |
NCT00010348: Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1 |
|
|
| Recruiting | 2 | 20 | US | Cyclosporine, Mycophenolate mofetil, Total body irradiation and stem cell or bone marrow transplantation | Fred Hutchinson Cancer Research Center | HIV Infections | 12/10 | 12/15 | | |
NCT01281423: Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV Infection |
|
|
| Active, not recruiting | 2 | 274 | US, Canada, RoW | Placebo, ANA598, Ribavirin, Pegylated Interferon | Hoffmann-La Roche | Hepatitis C | 11/12 | 05/13 | | |
|
|
NCT02031133: Long-term Extension to Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C |
|
|
| Active, not recruiting | 2 | 10 | US | Miravirsen | Santaris Pharma A/S | Hepatitis C | 01/17 | 01/17 | | |
NCT00436735: Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors |
|
|
| Active, not recruiting | 1 | 45 | US | midazolam hydrochloride, nelfinavir mesylate, gene expression analysis, polymerase chain reaction, protein expression analysis, immunoenzyme technique, immunologic technique, laboratory biomarker analysis, mass spectrometry | National Cancer Institute (NCI) | Colorectal Cancer, Gastrointestinal Carcinoid Tumor, Head and Neck Cancer, Islet Cell Tumor, Lung Cancer, Metastatic Cancer, Neuroendocrine Carcinoma of the Skin, Ovarian Cancer, Pheochromocytoma, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific | | | | |
NCT00046345: Atazanavir for HIV Infected Individuals: An Early Access Program |
|
|
| No Longer Available | N/A | | US | Atazanavir (BMS-232632) | Bristol-Myers Squibb | HIV Infections | | 07/03 | | |
NCT00096811: Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program |
|
|
| No Longer Available | N/A | | RoW | Entecavir, Baraclude | Bristol-Myers Squibb | Hepatitis B, Chronic Disease | 08/08 | 08/08 | | |
NCT00162227: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection |
|
|
| No Longer Available | N/A | | US | Efavirenz, Sustiva, BMS-561525 | Bristol-Myers Squibb | HIV Infection | 12/10 | 12/10 | | |
NCT00162188: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada |
|
|
| No Longer Available | N/A | | Canada | Efavirenz, Sustiva, BMS-561525 | Bristol-Myers Squibb | HIV Infection | 12/10 | 12/10 | | |
| Available | N/A | | US, RoW | Heat pack conduction-heat therapy | Universidad Peruana Cayetano Heredia, Tulane University School of Medicine | Cutaneous Leishmaniasis | | | | |
NCT02011932: Prospective Observational Study of Disease Progression in Chronic Hepatitis C |
|
|
| Active, not recruiting | N/A | 133 | RoW | | Beijing YouAn Hospital | Hepatitis C, Chronic, Disease Progression, Liver Cirrhosis | 06/11 | 07/30 | | |
| Active, not recruiting | N/A | 530 | Europe | Appendicectomy, Ertapenem | Turku University Hospital, Oulu University Hospital, Tampere University Hospital, Mikkeli Central Hospital, Jyväskylä Central Hospital, Seinajoki Central Hospital | Acute Appendicitis | 06/12 | 12/25 | | |
NCT00547235: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection |
|
|
| No Longer Available | N/A | | US | therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation, total-body irradiation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Infection, Precancerous/Nonmalignant Condition | 12/12 | | | |
NCT02028819: Compassionate Use of Ibalizumab for the Treatment of HIV Infection |
|
|
| No Longer Available | N/A | | US | Dolutegravir Sodium Monohydrate, TIVICAY, Ibalizumab, TMB-355 | University of Colorado, Denver | Human Immunodeficiency Virus (HIV) | 02/14 | 02/14 | | |
CITADEL, NCT01043861: AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD) |
|
|
| Active, not recruiting | N/A | 465 | US | | TYRX, Inc. | Implantable Cardioverter Defibrillator Infection | 07/14 | 07/14 | | |
| No Longer Available | N/A | | Europe, RoW | Telaprevir + peginterferon alfa + ribavirin, experimental, peginterferon alfa + ribavirin | Janssen-Cilag International NV | Hepatitis C | | | | |
|
|
|
|
|
|
|
|
|
NCT00975546: HIV-discordant Couple Intrauterine Insemination |
|
|
| No Longer Available | N/A | | US | Sperm washing and testing for HIV contamination, Intrauterine Insemination | University of Missouri-Columbia | Infertility, HIV Infections | | | | |
EAP CHALLAH, NCT01945619: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT |
|
|
| No Longer Available | N/A | | US | Trivirus-Specific CTLs | Baylor College of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital Research Institute, Children's Hospital Los Angeles, Duke University, Hackensack Meridian Health, New York Medical College, University of Texas Southwestern Medical Center, Children's National Research Institute, Johns Hopkins All Children's Hospital | EBV Infection, CMV Infection, Adenoviral Infection | | | | |
NCT02097966: EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C |
|
|
| No Longer Available | N/A | | Europe | Daclatasvir, BMS-790052, Sofosbuvir, Ribavirin | Bristol-Myers Squibb | Chronic Hepatitis C | | | | |
|
|
|
NCT02161939: A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C |
|
|
| No Longer Available | N/A | | US | Daclatasvir (BMS-790052), Sofosbuvir | Bristol-Myers Squibb | Chronic Hepatitis C | | | | |
|
| Recruiting | N/A | 660 | US | Silver Plated dressing, Silverlon, Telfa pad dressing, Telfa pad | Argentum Medical LLC | Surgical Site Infection, Cosmetic Appearance of Cesarean Scar, Post-operative Pain | 06/16 | | | |
| No Longer Available | N/A | | RoW | Technetium labelled glucosamine | University of Sydney, AbbVie | Rheumatoid Arthritis, Ankylosing Spondylitis | | | | |
NCT01776996: An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc |
|
|
| No Longer Available | N/A | | Europe, RoW | Continued Access Arm | ViiV Healthcare, GlaxoSmithKline | Infection, Human Immunodeficiency Virus | | | | |
NCT01306071: Observational Study of Persons With Hepatitis B Virus Infection in North America |
|
|
| Recruiting | N/A | 200 | US | | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative | | | | |
NCT00992654: A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India |
|
|
| No Longer Available | N/A | | NA | Open Label Treatment Access: Maraviroc, Maraviroc, Celsentri, Selzentry | ViiV Healthcare, Pfizer | Human Immunodeficiency Virus (HIV) | | | | |
DAD, NCT01238276: Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion |
|
|
| No Longer Available | N/A | | US | Cefazolin, Ancef, Kefzol, Silberg Tissue Preparation System, Silberg TPS (K023083), Tissue Preparation System, TPS, Mettler ME800 | Sonescence, Inc. | Infection, Soft Tissue, Infection, Wound, Cellulitis, Diabetic Foot Ulcer | | | | |
| Recruiting | N/A | 1800 | Europe | Prosthetic vascular graft, Valsalva Graft, Gelwave TM, Subclavia Graft, Gelwave TM, Longer Ante-Flo Offset branch, Gelwave TM, Lupiae Branched Graft, Gelwave TM, 4 Branched Plexus, Gelwave TM, Bifurcate, Gelwave TM soft, Subclavia Graft straight, Gelwave TM soft, Intergard woven straight, Intervascular "Maquet Getinge Group", Intergard woven hemabridge, Intervascular "Maquet Getinge Group", Intergard woven Aortic Arch, Intervascular "Maquet Getinge Group", Intergard Silver Knitted Bifurcation, Intervascular "Maquet Getinge Group", Intergard Silver Knitted Straight, Intervascular "Maquet Getinge Group", InterGard TM knitted Bifurcation, Intervascular "Maquet Getinge Group", FlowLine Bipore r Heparin ePTFE Vascular Graft, Jotec r GmbH, ePTFE Vascular Graft Regular Wall flex, IMPRA r, ePTFE Vascular Graft Thin Wall flex, IMPRA r, ePTFE Vascular Graft Regular Wall straight, IMPRA r, Gore-Tex Stretch Vascular Graft standard Wall Eptfe, W.L. Gore & Associates, Inl | University of Zurich, Schweizerischer Nationalfonds | Prosthetic Vascular Graft Infection | 03/23 | 03/23 | | |
NCT00537966: Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study |
|
|
| Recruiting | N/A | 2017 | Europe | Dolutegravir, Tivicay, Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate, Genvoya, Raltegravir, isentress, Darunavir, Prezista, Ritonavir, Norvir, Rilpivirine, Edurant, Lamivudine, 3TC, tenofovir, Viread, Emtricitabine, Emtriva, Abacavir, Ziagen | University of Zurich | HIV Infections | 01/25 | 01/25 | | |
NCT02217046: Decrease Implantation Site INFECTION : a Randomized Controlled Trial |
|
|
| Recruiting | N/A | 352 | RoW | device replacement(pocket capsule removal) | Yong Seog Oh | Infection | 08/25 | 10/25 | | |
NCT02149004: German Centre for Infection Research HIV Translational Platform |
|
|
| Recruiting | N/A | 10000 | Europe | | University Hospital of Cologne, German Center for Infection Research, German Federal Ministry of Education and Research | HIV | 01/35 | 01/35 | | |
NCT01821456: Cologne Cohort of Neutropenic Patients (CoCoNut) |
|
|
| Recruiting | N/A | 100000 | Europe | Antiinfectives, Antifungals, Antibacterials, Antivirals | University Hospital of Cologne | Hematological Malignancies, Cancer, Chemotherapy, Neutropenia, Immunosuppression | 12/50 | 12/50 | | |